Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Arcosa Inc is an infrastructure operations business based in the US. Arcosa shares (ACA) are listed on the NYSE and all prices are listed in US Dollars. Arcosa employs 6,170 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $46.31 |
|---|---|
| 52-week range | $43.38 - $59.77 |
| 50-day moving average | $51.42 |
| 200-day moving average | $52.31 |
| Wall St. target price | $65.57 |
| PE ratio | 30.6689 |
| Dividend yield | $0.2 (0.43%) |
| Earnings per share (TTM) | $1.51 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $46.31 from 2022-07-01
| 1 week (2022-06-27) | -1.99% |
|---|---|
| 1 month (2022-06-03) | -13.16% |
| 3 months (2022-04-04) | -19.14% |
| 6 months (2021-12-31) | -12.13% |
| 1 year (2021-07-02) | -20.21% |
|---|---|
| 2 years (2020-07-02) | 12.02% |
| 3 years (2019-07-03) | 27.26% |
| 5 years (2017-06-30) | N/A |
Valuing Arcosa stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Arcosa's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Arcosa's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 31x. In other words, Arcosa shares trade at around 31x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Arcosa's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 6.7234. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Arcosa's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Arcosa's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $282.4 million.
The EBITDA is a measure of a Arcosa's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.1 billion |
|---|---|
| Operating margin TTM | 6.18% |
| Gross profit TTM | $366.2 million |
| Return on assets TTM | 2.78% |
| Return on equity TTM | 3.8% |
| Profit margin | 3.47% |
| Book value | $40.94 |
| Market capitalisation | $2.2 billion |
TTM: trailing 12 months
Dividend payout ratio: 10.05% of net profits
Recently Arcosa has paid out, on average, around 10.05% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.43% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Arcosa shareholders could enjoy a 0.43% return on their shares, in the form of dividend payments. In Arcosa's case, that would currently equate to about $0.2 per share.
While Arcosa's payout ratio might seem low, this can signify that Arcosa is investing more in its future growth.
Arcosa's most recent dividend payout was on 28 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 13 July 2022 (the "ex-dividend date").
Over the last 12 months, Arcosa's shares have ranged in value from as little as $43.3808 up to $59.7659. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Arcosa's is 0.4484. This would suggest that Arcosa's shares are less volatile than average (for this exchange).
Arcosa, Inc. , together with its subsidiaries, provides infrastructure-related products and solutions for the construction, energy, and transportation markets in North America. It operates through three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment offers natural and recycled aggregates; specialty materials; and trench shields and shoring products for residential and non-residential construction, agriculture, specialty building products, as well as for infrastructure related projects. The Engineered Structures segment provides utility structures, wind towers, traffic and lighting structures, telecommunication structures, storage and distribution tanks for electricity transmission and distribution, wind power generation, highway road construction, and wireless communication markets, as well as for gas and liquids storage and transportation for residential, commercial, energy, agriculture, and industrial markets. The Transportation Products segment offers inland barges; fiberglass barge covers, winches, and other components; cast components for industrial and mining sectors; and axles, circular forgings, coupling devices for freight, tank, locomotive, and passenger rail transportation equipment, as well as other industrial uses. Arcosa, Inc.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.